Diabetes

Addition of orlistat benefits obese patients with T2DM

(HealthDay)—In overweight and obese patients with type 2 diabetes (T2D), treatment with orlistat in addition to lifestyle modifications improves outcomes, according to research published online Sept. 8 in Obesity Reviews.

Diabetes

Hippocampal insulin resistance linked to neuroplasticity

(HealthDay)—Hippocampal insulin resistance may be a key mediator of cognitive deficits, independent of glycemic control, according to an experimental study published online July 27 in Diabetes.

Diabetes

Durable response with insulin pump therapy in T2DM

(HealthDay)—Insulin pump therapy is more effective than multiple daily injections (MDI) for glycemic control in patients with type 2 diabetes, according to a study published online Feb. 8 in Diabetes, Obesity and Metabolism.

Diabetes

Very low carbohydrate diet beneficial for obese with T2DM

(HealthDay)—For obese adults with type 2 diabetes mellitus (T2DM), a very low carbohydrate diet is associated with greater improvements in glycemic control and cardiovascular risk markers than an energy-matched high unrefined ...

page 2 from 15